Hepatitis C Virus (HCV) Antibody CPT: 86803
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Expected Turnaround Time
Within 1-2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Red-top tube, gel-barrier tube, or lavender-top (EDTA) tube.
If tube other than a gel-barrier tube is used, transfer separated serum or plasma to a plastic transport tube.
To screen for and diagnose a hepatitis C virus (HCV) infection and to monitor treatment of the infection.
For screening: when you have risk factors for HCV infection or were born between 1945 and 1965, per 2012 CDC recommendations. For diagnosis: when you may have been exposed to the hepatitis C virus, such as through contact with infected blood, or have symptoms associated with liver disease.
A blood sample drawn from a vein in your arm.